Spontaneous Reporting-France

Pharmacovigilance: Second Edition

Volumn , Issue , 2007, Pages 217-226

  Moore, Nicholas ^a   Kreft Jais, Carmen ^b   Dhanani, Alban ^b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b AFSSAPS   (France)

Author keywords

Committee for Medicinal Products of Human Use (CHMP) of EMEA; French Agency for the Safety of Health Products (AFSSAPS); French Pharmacovigilance System; Scientific association (GIS) and INSERM; Spontaneous reporting France

Indexed keywords

EID: 77951115971     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470059210.ch16     Document Type: Chapter

References (14)

1. Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS) (2005) Bonnes pratiques de Pharmacovigilance. In: http://www.afssaps.sante.fr/pdf/5/5010. pdf; accessed Sept 15, 2006.
2. Begaud B, Evreux JC, Jouglard J, et al. (1985) Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France. Therapie 40(2): 111-18.
3. Benichou C (1990) Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 11(2): 272-6.
4. Benichou C, Solal Celigny P (1991) Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting. Nouv Rev Fr Hematol 33(3): 257-62.
5. Dangoumau J, Evreux JC, Jouglard J (1978) Method for determination of undesirable effects of drugs. Therapie 33(3): 373-81.
6. Fournier M, Camus P, Benichou C, et al. (1989) Interstitial pneumopathies: criteria of drug side-effects. Results of consensus meetings. Presse Med 18(27): 1333-6.
7. Habibi B, Solal-Celigny P, Benichou C, et al. (1988) Druginduced hemolytic anemia. Results of consensus conferences. Therapie 43(2): 117-20.
8. Montastruc JL, Chaumerliac C, Desboeuf K, et al. (2000) Adverse drug reactions to selegiline: a review of the French pharmacovigilance database. Clin Neuropharmacol 23(5): 271-5.
9. Moore N (2001) The role of the clinical pharmacologist in the management of adverse drug reactions. Drug Saf 24(1): 1-7.
10. Moore N, Biour M, Paux G, et al. (1985) Adverse drug reaction monitoring: doing it the French way. Lancet 2(8463): 1056-8.
11. Moore N, Noblet C, Joannides R, et al. (1993) Cough and ACE inhibitors. Lancet 341(8836): 61.
12. Moore N, Kreft-Jais C, Haramburu F, et al. (1997) Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database. Br J Clin Pharmacol 44(5): 513-18.
13. Roujeau JC, Beani JC, Dubertret L, et al. (1989) Drug-induced cutaneous photosensitivity. Results of a consensus meeting. Therapie 44(3): 223-7.
14. Vigeral P, Baumelou A, Benichou C, et al. (1989) Drug-induced renal insufficiency. Results of consensus meetings. Nephrologie 10(3): 157-61.